Sale!

GARS1 Gene CMT2D Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GARS1 Gene CMT2D Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the GARS1 gene that are associated with Charcot-Marie-Tooth disease type 2D (CMT2D). This condition is a type of inherited neurological disorder that affects the peripheral nerves, leading to muscle weakness and sensory problems primarily in the limbs. The test plays a crucial role in the early identification and management of CMT2D, enabling healthcare professionals to devise personalized treatment plans for affected individuals.

Performed using a sample of the patient’s blood, the test specifically looks for genetic alterations in the GARS1 gene, which encodes an enzyme essential for the proper functioning of peripheral nerves. Identifying mutations in this gene can confirm a diagnosis of CMT2D, distinguish it from other forms of Charcot-Marie-Tooth disease, and help in understanding the inheritance pattern within families.

The cost of the GARS1 Gene CMT2D Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the sophisticated genetic analysis required to detect the relevant mutations, providing crucial information for affected individuals and their families. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in genetics, ensuring accurate and reliable test results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GARS1 Gene CMT2D Genetic Test

At DNA Labs UAE, we offer the GARS1 Gene CMT2D Genetic Test to diagnose Charcot-Marie-Tooth disease type 2D (CMT2D), a hereditary neuropathy that affects the peripheral nerves. This test analyzes the DNA sequence of the GARS1 gene to identify any mutations or variations that may be causing the disease.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the GARS1 Gene CMT2D Genetic Test, it is important to provide the clinical history of the patient who is undergoing the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with GARS1 Gene CMT2D.

Test Details

The GARS1 gene is associated with Charcot-Marie-Tooth disease type 2D (CMT2D), a hereditary neuropathy that affects the peripheral nerves. Our NGS genetic test for CMT2D analyzes the DNA sequence of the GARS1 gene to identify any mutations or variations that may be causing the disease. This test can help diagnose CMT2D and provide information about the genetic risk for family members.

Treatment for CMT2D is supportive and may include physical therapy, occupational therapy, and medications to manage symptoms.

Test Name GARS1 Gene CMT2D Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GARS1 Gene CMT2D NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GARS1 Gene CMT2D
Test Details

The GARS1 gene is associated with Charcot-Marie-Tooth disease type 2D (CMT2D), a hereditary neuropathy that affects the peripheral nerves. The NGS genetic test for CMT2D analyzes the DNA sequence of the GARS1 gene to identify any mutations or variations that may be causing the disease. This test can help diagnose CMT2D and provide information about the genetic risk for family members. Treatment for CMT2D is supportive and may include physical therapy, occupational therapy, and medications to manage symptoms.